Press coverage about Imperva (NYSE:IMPV) has trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of press coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Imperva earned a media sentiment score of 0.14 on Accern’s scale. Accern also assigned headlines about the software maker an impact score of 46.3759516250224 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
These are some of the headlines that may have effected Accern Sentiment Analysis’s analysis:
- Needle Tilting Mid-Session For Imperva Inc (IMPV) - Financial News Review (finnewsreview.com)
- Imperva Inc (IMPV) Given Average Recommendation of “Hold” by Brokerages (americanbankingnews.com)
- Imperva Inc (IMPV) Price Lingering Above the Cloud - Evergreen Caller (evergreencaller.com)
- Imperva Inc (NYSE:IMPV) Receives Hold Rating from Stifel Nicolaus (americanbankingnews.com)
- Imperva, Inc. (IMPV) has a value of $50.35 per share While Sigma Designs, Inc. (SIGM) is stand at $6.10 - Stocks Gallery (stocksgallery.com)
Imperva (IMPV) traded up 1.97% on Tuesday, hitting $51.80. The stock had a trading volume of 326,094 shares. The company has a 50-day moving average of $49.16 and a 200 day moving average of $43.54. The company’s market cap is $1.73 billion. Imperva has a 12 month low of $34.40 and a 12 month high of $57.24.
Imperva (NYSE:IMPV) last issued its quarterly earnings results on Thursday, May 4th. The software maker reported ($0.29) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.62) by $0.33. The firm had revenue of $72.31 million for the quarter, compared to analyst estimates of $68.16 million. Imperva had a return on equity of 36.67% and a net margin of 31.92%. The business’s revenue was up 21.0% on a year-over-year basis. During the same period in the previous year, the company posted ($0.25) earnings per share. On average, analysts predict that Imperva will post $0.45 EPS for the current fiscal year.
A number of brokerages recently issued reports on IMPV. Stifel Nicolaus reiterated a “hold” rating and set a $47.00 price objective on shares of Imperva in a research note on Friday. Stephens reiterated an “overweight” rating and set a $61.00 price objective (up from $53.00) on shares of Imperva in a research note on Thursday, July 13th. ValuEngine downgraded Imperva from a “hold” rating to a “sell” rating in a research note on Tuesday, July 11th. BidaskClub downgraded Imperva from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 5th. Finally, Susquehanna Bancshares Inc began coverage on Imperva in a research note on Wednesday, June 7th. They set a “positive” rating and a $60.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and thirteen have assigned a buy rating to the stock. Imperva currently has an average rating of “Hold” and an average price target of $50.29.
TRADEMARK VIOLATION WARNING: This piece was published by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://stocknewstimes.com/2017/07/18/somewhat-positive-press-coverage-somewhat-unlikely-to-impact-imperva-impv-share-price.html.
In other news, SVP Sunil D. Nagdev sold 4,857 shares of Imperva stock in a transaction that occurred on Tuesday, May 16th. The stock was sold at an average price of $49.00, for a total value of $237,993.00. Following the sale, the senior vice president now directly owns 16,290 shares of the company’s stock, valued at $798,210. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Amichai Shulman sold 3,089 shares of Imperva stock in a transaction that occurred on Monday, May 15th. The stock was sold at an average price of $48.70, for a total value of $150,434.30. Following the completion of the sale, the insider now directly owns 100,151 shares in the company, valued at $4,877,353.70. The disclosure for this sale can be found here. Insiders sold 60,302 shares of company stock worth $2,875,861 over the last ninety days. Corporate insiders own 2.20% of the company’s stock.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.
